EUVIMEDOpdag EUVIMED
LeserbriefKommentar

Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir—potential influence of censored observation. Authors' reply

Chien-Hung Chen iD, Cheng-Yuan Peng iD

Alimentary Pharmacology & Therapeutics · 2024

DOI: 10.1111/apt.17788 ↗

At a glance

Leserbrief in Alimentary Pharmacology & Therapeutics, 2024. Written by Chien-Hung Chen and 1 co-authors. Institution: Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicin…. Major MEDLINE topics: Hepatitis B Surface Antigens, Antiviral Agents. 6 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

LINKED CONTENT This article is linked to Chen et al papers. To view these articles, visit https://doi.org/10.1111/apt.17602 and https://doi.org/10.1111/apt.17767

Subjects

MeSH terms (MEDLINE)

Hepatitis B Surface AntigensAntiviral AgentsHumansTenofovirIncidenceHepatitis B virusDNA, ViralHepatitis B e AntigensGuanine

Substances

TenofovirHepatitis B Surface AntigensAntiviral AgentsDNA, ViralHepatitis B e AntigensentecavirGuanine

Authors and institutions

  • Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan.
  • Center for Digestive Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
  • School of Medicine, China Medical University, Taichung, Taiwan.

ORCID profiles: Chien-Hung Chen, Cheng-Yuan Peng

Cite

APA

Chen, C. H., & Peng, C. Y. (2024). Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir—potential influence of censored observation. Authors' reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17788

Vancouver

Chen CH, Peng CY. Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir—potential influence of censored observation. Authors' reply. Alimentary Pharmacology & Therapeutics. 2024. doi:10.1111/apt.17788

BibTeX
@article{Chen2024,
  author = {Chen, Chien-Hung and Peng, Cheng-Yuan},
  title = {Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir—potential influence of censored observation. Authors' reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1111/apt.17788}
}
Start for free →